TIGER NASDAQ BIO
203780·Stock-Sector-Healthcare
Introduction
The TIGER NASDAQ BIO ETF seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the NASDAQ Biotechnology Index(Price Return)
Investment Points
ETF that diversely invests in global biotechnology or pharmaceutical companies listed in the United States
Benchmark Index
NASDAQ Biotechnology
Benchmark Index Description
An index consisting of stocks listed on the NASDAQ Stock Market®, classified under Biotechnology or Pharmaceuticals based on the Industry Classification Benchmark (ICB).
Issuer
Mirae Asset Global Investments Co.,Ltd.
Brand
TIGER
Fee
0.3
Listing Date
2014-08-27
ISIN
KR7203780002
Market Information
Market Capitalization57,281,400,000 KRW
Trading Value587,005,825 KRW
Trading Volume24,813
Number of Listed Shares2,420,000
NAV23,609
52-Week High25,210 KRW
52-Week Low19,965 KRW